Ginkgo Bioworks stock has lost 98% of its value since its SPAC debut. This may leave investors wondering if the stock is trading in "deep value" territory, or if it's a value trap. The original thesis for Ginkgo was quite interesting: using the power of nature to create organisms which can be made into new and exciting products. With such a promising value proposition, why has the stock performed so poorly? Let's take a look.

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/Y7zrXWR8_Gg.